Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-005038
Filing Date
2025-11-14
Accepted
2025-11-14 16:18:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16437
  Complete submission text file 0000902664-25-005038.txt   18330
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-89366 | Film No.: 251486613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 BRICKELL AVENUE, SUITE 2920 MIAMI FL 33131
Business Address 1111 BRICKELL AVENUE, SUITE 2920 MIAMI FL 33131 201-391-1839
C/M CAPITAL PARTNERS, LP (Filed by) CIK: 0002038499 (see all company filings)

EIN.: 991188042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A